Per NeoTract | Teleflex records, your current progress towards COE re-designation is below. Data reflect activities completed between April 2021 - March 2022. Please note that the data below are based on records reported to NeoTract | Teleflex. If this information is not correct, please contact the COE program team at UroLiftCOE@Teleflex.com.
View Re-designation Requirements
Note: To view your personal designation status, kindly enable cookie tracking on your browser settings. If you are unable to view your information, please contact us at UroLiftCOE@Teleflex.com.
| Designation Requirement | Overview of Requirement | Your Current Progress |
| No: of Cases |
Complete 60 cases within a 12-month period*. |
See chart below |
| Physician Education |
Complete 1 or more Teleflex Clinical and Medical Affairs (CMA)-led educational events after (Time frame) Qualifying educational events are listed below. |
|
| Patient Outcomes |
De-identified data from 30 UroLift System treated patients within a 12- month period*(Date of UroLift System Treatment) including: 1. Pre- and post-procedure IPSS data demonstrating mean improvement ≥ 40% compared to baseline average 2. Date of pre- and post-procedure assessment 3. BPH medication use at time of pre- and post-procedure assessment |
|
April 2021 |
May 2021 |
June 2021 |
July 2021 |
August 2021 |
|
September 2021 |
October 2021 |
November 2021 |
December 2021 |
January 2022 |
| February 2022 | March 2022 | April 2022 | May 2022 | June 2022 |
